Heart :: FDA recommends Bayer”s Trasylol for continued sale in US

The Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to the U.S. Food and Drug Administration (FDA) held a meeting to discuss the risk /benefit profile of Trasylol(R) (aprotinin injection), a Bayer drug used in coronary artery bypass graft (CABG) surgery.

Obesity :: New approach to fighting obesity and diabetes

World-first equipment, made exclusively for UQ scientists, will determine how to produce food which is better for us, but still tastes good. UQ researcher Professor Bob Gilbert said that while an unhealthy lifestyle and poor eating habits were significant factors in Australia’s obesity and diabetes epidemics, they were not entirely to blame.

Diabetes :: Long-term use of diabetes drug increases heart attack risk by more than 40 percent

An analysis of four studies involving more than 14,000 patients found that long-term use of the diabetes drug rosiglitazone (Avandia) increased the risk of heart attack by 42 percent and doubled the risk of heart failure, according to a new report from researchers at Wake Forest University School of Medicine and colleagues. There was no effect on death from cardiovascular causes.

Food :: Aspartame is safe, study says

A sweeping review of research studies of aspartame says there is no evidence that the non-nutritive sweetener causes cancer, neurological damage or other health problems in humans.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack